FLUOR CORPORATION (FLR) FY2026 Q2 Statement of Cash Flows

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
FLUOR CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Proceeds from the sale of NuScale shares → investing reconciliation: $472,000,000.00Proceeds from sales and maturities of marketable securities → investing reconciliation: $52,000,000.00Other → investing reconciliation: $3,000,000.00investing reconciliation → Net cash from investing activities: $349,000,000.00investing reconciliation → Purchases of marketable securities: $119,000,000.00investing reconciliation → Investments in partnerships and joint ventures: $52,000,000.00investing reconciliation → Capital expenditures: $7,000,000.00Capital contributions by NCI → financing reconciliation: $37,000,000.00Other → financing reconciliation: $2,000,000.00financing reconciliation → Repurchase of common stock: $300,000,000.00financing reconciliation → Distributions paid to NCI: $27,000,000.00Net cash used in operating activities → operating reconciliation: $317,000,000.00Net earnings → operating reconciliation: $124,000,000.00Depreciation → operating reconciliation: $16,000,000.00Stock-based compensation → operating reconciliation: $10,000,000.00Equity method earnings, net of taxes → operating reconciliation: $7,000,000.00Other → operating reconciliation: $1,000,000.00operating reconciliation → Changes in assets and liabilities: $466,000,000.00operating reconciliation → Deferred taxes: $9,000,000.00Net cash used in financing activities → financing reconciliation: $288,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $3,187,000,000.00Net cash from investing activities → Cash sources and uses: $349,000,000.00Cash sources and uses → Exchange-rate effect: $8,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $2,923,000,000.00Cash sources and uses → Net cash used in financing activities: $288,000,000.00Cash sources and uses → Net cash used in operating activities: $317,000,000.00Other: $1,000,000.00Other non-cash items+$1.00 MChanges in assets and liabilities: -$466,000,000.00Other working capital, net−$466.00 MNet earnings: $124,000,000.00Net earnings+$124.00 MGain on sales of assets (including the sale of CFHI in 2026): $0.00Deferred taxes: -$9,000,000.00Deferred taxes & credits−$9.00 MStock-based compensation: $10,000,000.00Stock-based compensation+$10.00 MEquity method earnings, net of taxes: $7,000,000.00Subsidiary stock sale gain/loss+$7.00 MDepreciation: $16,000,000.00Depreciation & amortization+$16.00 MNet cash used in operating activities: -$317,000,000.00. Cash required to fund net payments.Operating cash−$317.00 Moperating reconciliation: $475,000,000.00Repurchase of common stock: -$300,000,000.00Common stock repurchases−$300.00 MPurchase and retirement of debt: $0.00Other: $2,000,000.00Other financing, net+$2.00 MCapital contributions by NCI: $37,000,000.00From noncontrolling interests+$37.00 MDistributions paid to NCI: -$27,000,000.00Noncontrolling dividends−$27.00 MNet cash used in financing activities: -$288,000,000.00. Cash required to fund net payments.Financing cash−$288.00 Mfinancing reconciliation: $327,000,000.00Proceeds from the sale of NuScale shares: $472,000,000.00Joint venture proceeds+$472.00 MPurchases of marketable securities: -$119,000,000.00Marketable securities purchases−$119.00 MProceeds from sales and maturities of marketable securities: $52,000,000.00Marketable securities proceeds+$52.00 MCapital expenditures: -$7,000,000.00PP&E purchases−$7.00 MProceeds from sales of assets (including the sale of CFHI in 2026): $0.00Investments in partnerships and joint ventures: -$52,000,000.00Investments in affiliates−$52.00 MOther: $3,000,000.00Other investing, net+$3.00 MNet cash from investing activities: $349,000,000.00Investing cash+$349.00 Minvesting reconciliation: $527,000,000.00Cash sources and uses: $3,536,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $3,187,000,000.00Beginning cash$3.19 BEnding cash: Cash, cash equivalents, and restricted cash: $2,923,000,000.00Ending cash$2.92 BExchange-rate effect: -$8,000,000.00FX effect−$8.00 MCASH RECONCILIATIONInvestingflowsFinancingflowsOperatingflowsFree cash flow−$324.00 MOperating cash − cash spent on PP&ECash flow / Net income−2.56×Operating cash flow ÷ net incomeNet cash change−$264.00 MEnding cash − beginning cash
Chart details

FLUOR CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
3,187,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
negative 317,000,000 US dollars. Net cash used.
Other
1,000,000 US dollars
Changes in assets and liabilities
negative 466,000,000 US dollars
Net earnings
124,000,000 US dollars
Gain on sales of assets (including the sale of CFHI in 2026)
0 US dollars
Deferred taxes
negative 9,000,000 US dollars
Stock-based compensation
10,000,000 US dollars
Equity method earnings, net of taxes
7,000,000 US dollars
Depreciation
16,000,000 US dollars
Investing activities
349,000,000 US dollars. Net cash provided.
Proceeds from the sale of NuScale shares
472,000,000 US dollars
Purchases of marketable securities
negative 119,000,000 US dollars
Proceeds from sales and maturities of marketable securities
52,000,000 US dollars
Capital expenditures
negative 7,000,000 US dollars
Proceeds from sales of assets (including the sale of CFHI in 2026)
0 US dollars
Investments in partnerships and joint ventures
negative 52,000,000 US dollars
Other
3,000,000 US dollars
Financing activities
negative 288,000,000 US dollars. Net cash used.
Repurchase of common stock
negative 300,000,000 US dollars
Purchase and retirement of debt
0 US dollars
Other
2,000,000 US dollars
Capital contributions by NCI
37,000,000 US dollars
Distributions paid to NCI
negative 27,000,000 US dollars
Operating adjustment reconciliation
475,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
327,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
527,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 8,000,000 US dollars
Ending cash on Jun 30, 2026
2,923,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
3,536,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 264,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
−2.56×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
negative 317,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
7,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
negative 324,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income or operating cash is negative. The full signed reconciliation is retained: losses remain deductions, and any negative operating-cash total enters the junction from the cash pool. No positive direct-income connection is implied.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Cash-flow net income is $124.00 M, derived by subtracting the earlier cumulative period; the income statement reports $123.00 M for the same period. The $1.00 M difference is rounding: the filing reports each amount rounded to the nearest million dollars, and the quarter is the difference of two rounded year-to-date amounts. Neither amount has been adjusted.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 317,000,000 US dollars minus 7,000,000 US dollars equals negative 324,000,000 US dollars.
  • Cash-flow net income is $124.00 M, derived by subtracting the earlier cumulative period; the income statement reports $123.00 M for the same period. The $1.00 M difference is rounding: the filing reports each amount rounded to the nearest million dollars, and the quarter is the difference of two rounded year-to-date amounts. Neither amount has been adjusted.
FLUOR CORPORATION (FLR) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!